Ameloblastic carcinoma: A systematic review
- PMID: 38368851
- DOI: 10.1111/jop.13517
Ameloblastic carcinoma: A systematic review
Abstract
Background: Ameloblastic carcinoma (AC) is the most common odontogenic malignancy, constituting approximately 30% of cases in this category. Literature is sparse on malignant odontogenic neoplasms, with a large proportion of current knowledge derived from case reports or small case series.
Methods: A systematic review of case series/case reports of AC was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement guidelines. Demographic and clinical information, including duration of the lesion, location, clinical presentation and radiologic features, were analysed. Additionally, the origin of the lesion (primary/secondary), Ki-67 proliferation index, treatment performed, metastasis, tumour recurrence and prognosis were collected for analysis.
Results: A total of 126 studies, including 285 individual cases of AC, were included in this review. Patients presented with a near-equal distribution of painless and painful swellings. ACs presented at a median age of 45 years, with a male-to-female ratio of 1:2. The mandible was most frequently involved, with rare cases extending to involve more than one region, including crossing the midline. Although most lesions presented with poorly-demarcated borders (52.6%), unilocular lesions with well-demarcated borders (47.4%) comprised a substantial number in the sample. The proliferation index was only reported in 27 cases, with a mean score of 42% and a wide range. The probability of tumour recurrence increased, and the survival probability decreased with prolonged follow-up duration.
Conclusion: This study provides more comprehensive, up-to-date descriptive data on these rare odontogenic malignancies, aiding clinicians and Pathologists with the diagnosis and surgeons in their management of cases.
Keywords: ameloblastic carcinoma; head and neck cancer; odontogenic neoplasms; recurrence rates; survival probability.
© 2024 The Authors. Journal of Oral Pathology & Medicine published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Odell EW. Chapter 7: Odontogenic and maxillofacial bone tumours. World Health Organization Classification of Tumours Editorial Board. Head and Neck Tumours. 5th ed. Lyon (France): International Agency for Research on Cancer; 2022.
-
- Richardson MS, Muller S. Malignant odontogenic tumors: an update on selected tumors. Head Neck Pathol. 2014;8(4):411-420.
-
- Soluk-Tekkesin M, Wright JM. The World Health Organization Classification of Odontogenic Lesions: a summary of the changes of the 2022 (5th) edition. Turk Patoloji Derg. 2022;38(2):168-184.
-
- Niu Z, Li Y, Chen W, et al. Study on clinical and biological characteristics of ameloblastic carcinoma. Orphanet J Rare Dis. 2020;15(1):316.
-
- Vered M, Wright JM. Update from the 5th edition of the World Health Organization classification of head and neck tumors: odontogenic and maxillofacial bone tumours. Head Neck Pathol. 2022;16(1):63-75.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources